Glycopyrronium (25mcg) + Formoterol (12mcg)+ Budesonide (400 mcg) Glycopryl FB

Home/Products /glycopyrronium-25mcg-formoterol-12mcg-budesonide-rota-cap

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Glycopyrronium 25mcg + Formoterol 12mcg + Budesonide 400mcg at Best Price for PCD Pharma Franchise in Respiratory Care

Glycopyrronium 25mcg + Formoterol 12mcg + Budesonide 400mcg at Best Price from Leading 3rd Party Manufacturers in India for Asthma and COPD

Glycopyrronium 25mcg + Formoterol 12mcg + Budesonide 400mcg at Best Price from Top Pharmaceutical Exporters in India for Pulmonary Care

Glycopyrronium 25mcg + Formoterol 12mcg + Budesonide 400mcg at Best Price from Top Pharma Companies in India for Asthma & COPD

Glycopryl FB Best Price in Respiratory Care Franchise for Asthma & COPD Management

Glycopryl FB

Composition : "Glycopyrronium (25mcg) + Formoterol (12mcg)+ Budesonide (400 mcg)"

Dosage Form : Rota cap

Packaging Type :

Packaging :

Price : ₹1/-

Please Contact For Best Price

Glycopryl FB is a powerful inhalation therapy designed for the effective management of chronic obstructive pulmonary disease (COPD) and asthma. Each Rota Cap contains a carefully balanced combination of Glycopyrronium (25 mcg), Formoterol (12 mcg), and Budesonide (400 mcg). This unique formulation targets multiple pathways to provide comprehensive relief from respiratory symptoms, improving overall lung function and quality of life.

Glycopyrronium is an anticholinergic agent that helps to relax the muscles around the airways, leading to bronchodilation and improved airflow. Formoterol, a long-acting beta-agonist (LABA), complements this effect by stimulating beta-2 adrenergic receptors, further enhancing bronchodilation and providing prolonged relief from wheezing and shortness of breath. Budesonide, an inhaled corticosteroid (ICS), works to reduce inflammation in the airways, addressing the underlying causes of asthma and COPD. Together, these three components create a synergistic effect that not only alleviates symptoms but also helps to prevent exacerbations.

About the Product

Common side effects may include throat irritation, hoarseness, headache, and increased risk of respiratory infections. Some patients may also experience palpitations or muscle cramps. It is important to monitor for any unusual symptoms during treatment.

Glycopryl FB is indicated for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) in adults.

Glycopryl FB should be used only as directed by a healthcare professional. Do not exceed the recommended dosage, and consult a doctor if symptoms do not improve or worsen.